Latest News & Features
Americas
US pharmaceutical company Depomed has won a patent case in the US District Court for the District of New Jersey against three filers of Abbreviated New Drug Applications covering Nucynta. 4 October 2016
Americas
Allergan and MedImmune have entered into a $1.52 billion licensing agreement under which Allergan has gained the global rights to develop MEDI2070, which treats inflammatory disorders. 4 October 2016
Americas
The $3.6 billion acquisition of the Thomson Reuters Intellectual Property & Science business by Onex Corporation and Baring Equity Asia was completed yesterday. 4 October 2016
Americas
Biopharmaceutical company Amgen and drug manufacturer Arrowhead Pharmaceuticals have entered into two agreements to develop and commercialise RNA interference therapies for cardiovascular disease. 3 October 2016
Americas
US drugs company Pfizer has filed a complaint against India-based generics company Aurobindo Pharma for allegedly infringing it patents centring on the drug Toviaz. 3 October 2016
Africa
More than 1,000 protesters representing different patient groups marched on September 27 in Pretoria, South Africa, to demand that the Department of Trade and Industry amends the patent law on medicine supply. 30 September 2016
Americas
Amgen has filed a complaint against Cipla for allegedly infringing a patent centring on Sensipar, which treats an overactive thyroid. 30 September 2016
Big Pharma
Fake drugs cost EU pharmaceutical companies up to €10.2 billion annually, a new report from the European Union Intellectual Property Office has revealed. 29 September 2016
Big Pharma
Biotechnology company Oncodesign is set to acquire pharmaceutical company GSK’s François Hyafil Research Centre in Essonne, France. 29 September 2016
Americas
Biotechnology company Genzyme has sued generic manufacturer Mylan in a lawsuit claiming that the company has infringed one of Genzyme’s patents covering the Clolar injection drug. 28 September 2016